Center for Hip and Knee Replacement, Columbia University Medical Center, New York, NY.
Department of Orthopaedic Surgery, NYU Hospital for Joint Diseases, NYU Langone Health, New York, NY.
J Bone Joint Surg Am. 2018 Jul 5;100(13):1141-1146. doi: 10.2106/JBJS.17.01177.
In the last decade, the widespread use of regional anesthesia in total knee arthroplasty has led to improvements in pain control, more rapid functional recovery, and reductions in the length of the hospital stay. The aim of this study was to compare the efficacy of adductor canal blocks (ACB) and periarticular anesthetic injections (PAI), both with bupivacaine, for pain management in total knee arthroplasty.
One hundred and fifty-five patients undergoing primary total knee arthroplasty under spinal anesthesia were randomized to 1 of 3 groups: ACB alone (15 mL of 0.5% bupivacaine), PAI alone (50 mL of 0.25% bupivacaine with epinephrine), and ACB+PAI. The primary outcome in this study was the visual analog scale (VAS) pain score in the immediate postoperative period. Secondary outcomes included postoperative opioid use, activity level during physical therapy, length of hospital stay, and knee range of motion.
The mean VAS pain score was significantly higher after use of ACB alone, compared with the score after use of ACB+PAI, on postoperative day 1 (POD1) (3.9 versus 3.0, p = 0.04) and POD3 (4.2 versus 2.0, p = 0.02). Total opioid consumption through POD3 was significantly higher when ACB alone had been used (131 morphine equivalents [ME]) compared with PAI alone (100 ME, p = 0.02) and ACB+PAI (98 ME, p = 0.02). Opioid consumption in the ACB-alone group was significantly higher than that in the ACB+PAI group on POD2 and POD3 and significantly higher than that in the PAI-alone group on POD2. There was no significant difference in opioid consumption between the patients treated with PAI alone and those who received ACB+PAI. The activity level during physical therapy on POD0 was significantly lower after use of ACB alone (26 steps) than after use of PAI alone (68 steps, p < 0.001) or ACB+PAI (65 steps, p < 0.001).
This randomized controlled clinical trial demonstrated significantly higher pain scores and opioid consumption after total knee arthroplasty done with an ACB and without PAI, suggesting that ACB alone is inferior for perioperative pain control. There were no significant differences between PAI alone and ACB+PAI with regard to pain or opioid consumption.
Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.
在过去的十年中,在全膝关节置换术中广泛使用区域麻醉导致疼痛控制得到改善,功能恢复更快,住院时间缩短。本研究的目的是比较股神经沟阻滞(ACB)和关节周围麻醉注射(PAI)联合布比卡因在全膝关节置换术后疼痛管理中的疗效。
155 例在脊髓麻醉下接受初次全膝关节置换术的患者随机分为 3 组:单独使用 ACB(15 毫升 0.5%布比卡因)、单独使用 PAI(50 毫升 0.25%布比卡因加肾上腺素)和 ACB+PAI。本研究的主要结局是术后即刻视觉模拟评分(VAS)疼痛评分。次要结局包括术后阿片类药物使用、物理治疗期间的活动水平、住院时间和膝关节活动范围。
单独使用 ACB 后,与 ACB+PAI 相比,术后第 1 天(POD1)(3.9 对 3.0,p=0.04)和第 3 天(POD3)(4.2 对 2.0,p=0.02)的 VAS 疼痛评分明显更高。单独使用 ACB 时,到 POD3 的总阿片类药物消耗量(131 吗啡当量[ME])明显高于单独使用 PAI(100 ME,p=0.02)和 ACB+PAI(98 ME,p=0.02)。在 POD2 和 POD3 时,ACB 组的阿片类药物消耗量明显高于 ACB+PAI 组,在 POD2 时,ACB 组的阿片类药物消耗量明显高于 PAI 组。单独使用 PAI 的患者和接受 ACB+PAI 的患者之间的阿片类药物消耗量没有显著差异。单独使用 ACB 后,POD0 时物理治疗期间的活动水平(26 步)明显低于单独使用 PAI(68 步,p<0.001)或 ACB+PAI(65 步,p<0.001)。
这项随机对照临床试验表明,单独使用 ACB 而不使用 PAI 行全膝关节置换术后疼痛评分和阿片类药物消耗量明显升高,提示单独使用 ACB 不利于围手术期疼痛控制。单独使用 PAI 和 ACB+PAI 在疼痛或阿片类药物消耗方面无显著差异。
治疗水平 I. 请参阅作者说明,以获取完整的证据水平描述。